ClassID:

20918

A61K38/1709 - page 4 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#901
20220211809
2022-07-07

TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF

#902
20220211807
2022-07-07

TREATMENT OF CILIOPATHIES

#903
20220211624
2022-07-07

FUSION PROTEIN NANODISK COMPOSITIONS AND METHODS OF TREATMENT

#904
20220204924
2022-06-30

ENGINEERED ENDOTHELIAL CELLS EXPRESSING AN ETS TRANSCRIPTION FACTOR

#905
20220204576
2022-06-30

ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS

#906
20220204572
2022-06-30

TARGETING DEREGULATED WNT SIGNALING IN CANCER USING STABILIZED ALPHA-HELICES OF BCL-9

#907
20220202896
2022-06-30

COMPOSITION FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS

#908
20220195461
2022-06-23

METHODS AND COMPOSITIONS FOR TRANSGENE EXPRESSION

#909
20220194984
2022-06-23

Immunotherapy against several tumors including lung cancer

#910
20220193265
2022-06-23

METHODS AND COMPOSITIONS FOR REPROGRAMMING MÜLLER GLIA

#911
20220193260
2022-06-23

PROTEINS WITH CARDIOPROTECTIVE ACTIVITY

#912
20220193247
2022-06-23

Novel Codon-Optimized CFTR MRNA

#913
20220193193
2022-06-23

METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING SLIT2

#914
20220193192
2022-06-23

METHODS OF TREATING A TRAUMATIC BRAIN INJURY

#915
20220193191
2022-06-23

LIPOCALIN MUTEIN FOR TREATMENT OF ASTHMA

#916
20220193190
2022-06-23

PHARMACEUTICAL COMPOSITION COMPRISING FRATAXIN FUSION PROTEIN AND METHODS OF USE THEREOF

#917
20220193189
2022-06-23

USE OF Dvl3-DEP PEPTIDE IN PREPARATION OF MEDICAMENT FOR REPAIRING SERTOLI CELL INJURY IN TESTES

#918
20220193150
2022-06-23

Method and System for Reducing the Likelihood of Developing Depression in an Individual

#919
20220184177
2022-06-16

Polypeptides for treatment of cancer

#920
20220184176
2022-06-16

AMPHIPHYSIN / BIN1 FOR THE TREATMENT OF AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY

#921
20220184175
2022-06-16

TREATMENT OF AGING OR AGE-RELATED DISORDERS USING XBP1

#922
20220177548
2022-06-09

Methods and Compositions for Treating Melanoma

#923
20220175882
2022-06-09

BETA-CASEIN A2 AND REDUCING OR PREVENTING SYMPTOMS OF LACTOSE INTOLERANCE

#924
20220168388
2022-06-02

METHODS AND COMPOSITIONS FOR TUSC2 IMMUNOTHERAPY

#925
20220168387
2022-06-02

INHALED ADMINISTRATION OF LIPOCALIN MUTEINS

#926
20220162315
2022-05-26

Combination Immunotherapy For The Treatment of Cancer

#927
20220160830
2022-05-26

COMPOSITIONS COMPRISING CHOLINE

#928
20220160829
2022-05-26

USE OF ANNEXIN V AS A METHOD TO BLOCK TUMOR INDUCED IMMUNOSUPPRESSION OF THE INNATE IMMUNE RESPONSE

#929
20220160827
2022-05-26

TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED mRNA ENCODING CFTR

#930
20220160826
2022-05-26

Method of using PRD, PRD-S TAD, ZF7 peptide or mixture thereof to inhibit cellular response to inflammatory stimuli or treat cytokine-storm-mediated diseases

#931
20220160825
2022-05-26

BRAIN REPAIR AFTER TRAUMATIC BRAIN INJURY THROUGH NEUROD1-MEDIATED ASTROCYTE-TO-NEURON CONVERSION

#932
20220160784
2022-05-26

METHODS AND COMPOSITIONS OF CHONDRISOMES

#933
20220160664
2022-05-26

TAZ ACTIVATORS AND WNT AGONISTS FOR TREATING EAR DISORDERS

#934
20220154278
2022-05-19

COMPOSITIONS FOR DIAGNOSIS, PREVENTION, OR TREATMENT OF FATTY LIVER DISEASE

#935
20220154188
2022-05-19

COMPOSITIONS AND METHODS FOR IN VIVO EXCISION OF HIV-1 PROVIRAL DNA

#936
20220152322
2022-05-19

Dry powder inhaler and system for drug delivery

#937
20220152165
2022-05-19

COMBINATION OF NASAL GENE DELIVERY AND ORAL CINNAMIC ACID, OLEAMIDE OR GEMFIBROZIL FOR LYSOSOMAL STOARGE DISORDERS

#938
20220152158
2022-05-19

Irisin improves placental function during pregnancy

#939
20220152149
2022-05-19

Annexin-coated particles

#940
20220143142
2022-05-12

DIRECT REPROGRAMMING OF CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES USING AN ENDOTHELIAL CELL TRANSDIFFERENTIATION STRATEGY

#941
20220143139
2022-05-12

Modulating Neuroinflammation

#942
20220143138
2022-05-12

Compositions for treating heart disease by inhibiting the action of mAKAP-β

#943
20220143136
2022-05-12

USE OF ANNEXINS IN PREVENTING AND TREATING MUSCLE MEMBRANE INJURY

#944
20220143134
2022-05-12

Method for treating disease using FOXP3+CD4+ T cells

#945
20220143099
2022-05-12

METHODS TO ENHANCE T CELL REGENERATION

#946
20220137070
2022-05-05

METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS

#947
20220133911
2022-05-05

MYC, CYCLIN T1 AND/OR CDK9 FOR USE IN THE TREATMENT OF DEGENERATIVE HEART AND CNS DISORDERS

#948
20220133852
2022-05-05

Reconstituted high density lipoprotein formulation and production method thereof

#949
20220133851
2022-05-05

IMMUNOPOTENTIATING OR ANTICANCER ACTIVITY-AUGMENTING COMPOSITION COMPRISING MAL-EXPRESSED STEM CELL LIKE MEMORY T CELL AS ACTIVE INGREDIENT

#950
20220133766
2022-05-05

MODULATION OF CILIOGENESIS

#951
20220127226
2022-04-28

ANTI-ARRHYTHMICITY AGENTS

#952
20220125920
2022-04-28

COMBINATION THERAPY FOR TREATMENT OF CORONARY ARTERY DISEASE

#953
20220125891
2022-04-28

METHOD FOR TREATING AND/OR PREVENTING REGNASE-1-RELATED DISEASE

#954
20220125881
2022-04-28

Method for preparing a bone protein preparation and a bone protein preparation

#955
20220125879
2022-04-28

ALBUMIN-BOUND COMPOSITION INCLUDING LRRD2 OF SLIT3 PROTEIN FOR PREVENTION OR TREATMENT OF BONE-RELATED DISEASES

#956
20220118101
2022-04-21

COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING INFLAMMATION BY INHIBITING CASPASE-9

#957
20220118089
2022-04-21

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE CONDITIONS WITH ECM-AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS

#958
20220118068
2022-04-21

Modulation of proprotein convertase subtilisin/kexin 9 expression (PCSK9) with HSP 27 and/or HSP25

#959
20220118059
2022-04-21

COMPOSITION AND METHODS FOR MODULATION OF ELOVL2

#960
20220118048
2022-04-21

HYALURONIC ACID STABILIZER

#961
20220118031
2022-04-21

Method and System to Improve the Health of a Person's Skin Microbiome

#962
20220111005
2022-04-14

COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS

#963
20220111003
2022-04-14

Neuroprotective peptides

#964
20220110977
2022-04-14

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS

#965
20220105153
2022-04-07

USE OF PROTEIN-BASED LONG-ACTING PREPARATION IN IMPROVING SEXUAL DYSFUNCTION

#966
20220105152
2022-04-07

Composition for and Method of Treating Hepatic Tissue Injury

#967
20220105151
2022-04-07

ASARM TREATMENT FOR KIDNEY AND MINERALIZATION DISORDERS AND HYPERPHOSPHATEMIA

#968
20220104468
2022-04-07

MODULATION OF LC3-ASSOCIATED ENDOCYTOSIS PATHWAY AND GENETICALLY MODIFIED NON-HUMAN ANIMALS AS A MODEL OF NEUROINFLAMMATION AND NEURODEGENERATION

#969
20220098255
2022-03-31

NEUROD1 COMBINATION VECTOR

#970
20220098251
2022-03-31

PEPTIDE TAGS FOR LIGAND INDUCED DEGRADATION OF FUSION PROTEINS

#971
20220098243
2022-03-31

Selective recovery

#972
20220096715
2022-03-31

STRUCTURED GELS

#973
20220096597
2022-03-31

CARDIO-PROTECTIVE EFFECT OF VASOCONSTRICTION-INHIBITING FACTOR (VIF)

#974
20220096560
2022-03-31

METHODS AND COMPOSITIONS RELATING TO MESENCHYMAL STEM CELL EXOSOMES

#975
20220096380
2022-03-31

ORAL FORMULATIONS OF A BIOLOGICALLY ACTIVE PEPTIDE AND USES THEREOF

#976
20220089726
2022-03-24

TREATMENT OF DISEASES RELATED TO COLONY-STIMULATING FACTOR 1 RECEPTOR DYSFUNCTION USING TREM2 AGONISTS

#977
20220088143
2022-03-24

ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM

#978
20220088133
2022-03-24

Nanoliposome Compositions And Methods Of Treating Stroke

#979
20220088127
2022-03-24

TARGETING THE BAG FAMILY FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE

#980
20220088126
2022-03-24

PHARMACEUTICAL COMPOSITION COMPRISING RUNX3 GENE OR PROTEIN AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF K-RAS MUTANT LUNG CANCER

#981
20220088125
2022-03-24

Pharmaceutical composition comprising PIBF protein as active ingredient for prevention or treatment of inflammatory disease

#982
20220088124
2022-03-24

COMPOSITIONS AND METHODS FOR TREATING NECROTIZING ENTEROCOLITIS

#983
20220080027
2022-03-17

METHODS OF TREATING NEURODEGENERATIVE DISEASES BY TARGETING THE PURINERGIC AND/OR ADENOSINE RECEPTORS

#984
20220073488
2022-03-10

Compositions comprising an urolithin compound

#985
20220072158
2022-03-10

ISL1-BASED GENE THERAPY TO TREAT HEARING LOSS

#986
20220072153
2022-03-10

REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF DISEASE AND INJURY IN THE NERVOUS SYSTEM

#987
20220072102
2022-03-10

Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

#988
20220072096
2022-03-10

WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA

#989
20220072095
2022-03-10

METHODS AND COMPOSITIONS FOR TREATING SKIN DISEASES

#990
20220072062
2022-03-10

CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF MUSCULAR DYSTROPHY

#991
20220071905
2022-03-10

PEG lipidoid compounds

#992
20220071899
2022-03-10

DRINKABLE INFANT COMPOSITIONS

#993
20220064378
2022-03-03

Star Polypeptides

#994
20220064220
2022-03-03

Immunotherapy against several tumors including lung cancer

#995
20220062418
2022-03-03

TUMOR TARGETING VITAMIN B12 DERIVATIVES FOR X-RAY ACTIVATED CHEMOTHERAPY

#996
20220062389
2022-03-03

METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES USING FNDC5

#997
20220062379
2022-03-03

METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION

#998
20220062378
2022-03-03

Methods of treating or inhibiting onset of Huntington's disease

#999
20220062377
2022-03-03

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INTELLECTUAL DISABILITIES

#1000
20220062299
2022-03-03

USE OF GLUCOCORTICOID STEROIDS IN PREVENTING AND TREATING CONDITIONS OF MUSCLE WASTING, AGING AND METABOLIC DISORDER

#1001
20220056088
2022-02-24

PEPTIDE DIRECTED PROTEIN KNOCKDOWN

#1002
20220054657
2022-02-24

Gene therapy for retinitis pigmentosa

#1003
20220054654
2022-02-24

APPLICATION OF ECM1 IN PREVENTION AND/OR TREATMENT OF LIVER FIBROSIS-RELATED DISEASES

#1004
20220054607
2022-02-24

GLIAL FIBRILLARY ACIDIC PROTEIN TARGETING IMMUNO- AND APTAMER-BASED-THERAPY FOR NEUROINJURY, NEURODEGENERATION, NEURO-DISEASE, AND NEURO-REPAIR

#1005
20220054588
2022-02-24

USE OF SAP FOR THE TREATMENT OF EUROTIOMYCETES FUNGI INFECTIONS

#1006
20220054587
2022-02-24

Compositions and methods of use for secretoglobins to protect the glycocalyx via interactions with heparan sulfate proteoglycan proteins

#1007
20220047821
2022-02-17

DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY

#1008
20220047672
2022-02-17

COMPOSITIONS AND METHODS INVOLVING LAYILIN

#1009
20220047501
2022-02-17

Method of treating osteoarthritis

#1010
20220041671
2022-02-10

MODIFIED LIGAND-GATED ION CHANNELS AND METHODS OF USE

#1011
20220041670
2022-02-10

ACTRIIB PROTEINS AND VARIANTS AND USES THEREFORE RELATING TO UTROPHIN INDUCTION FOR MUSCULAR DYSTROPHY THERAPY

#1012
20220040259
2022-02-10

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1013
20220040258
2022-02-10

GASTRO-RESISTANT MICROENCAPSULATES, AND USES THEREOF TO STIMULATE IN-VIVO ILEAL GLP-1 RELEASE IN A MAMMAL

#1014
20220040257
2022-02-10

METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING ATHEROSCLEROSIS AND RELATED DISEASES

#1015
20220040185
2022-02-10

Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection

#1016
20220031805
2022-02-03

Therapeutic method of treatment for inhibiting tumor development using Tamm-Horsfall glycoprotein (THP) as immunostimulating drug and compositions

#1017
20220031804
2022-02-03

Therapeutic agent of uremia containing alarin as the main ingredient

#1018
20220026443
2022-01-27

Marker for diagnosing atherosclerosis severity, and diagnostic method using same

#1019
20220025328
2022-01-27

Inhibition of cytokine-induced SH2 protein in NK cells

#1020
20220025048
2022-01-27

Inhibition of cytokine-induced SH2 protein in NK cells

#1021
20220025005
2022-01-27

Erythropoietin Analogs For Veterinary Use

#1022
20220023383
2022-01-27

Pharmaceutical compositions and methods targeting Wnt pathway proteins

#1023
20220023382
2022-01-27

VDAC INHIBITORS FOR TREATING INFLAMMATORY BOWEL DISEASES

#1024
20220023381
2022-01-27

VDAC INHIBITORS FOR TREATING AUTOIMMUNE DISEASES

#1025
20220023380
2022-01-27

Compositions and methods for inhibiting intercellular interactions

#1026
20220018858
2022-01-20

Therapeutic and diagnostic methods and compositions for neurodegenerative diseases

#1027
20220016209
2022-01-20

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1028
20220016207
2022-01-20

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1029
20220016206
2022-01-20

Isoform Nell-1 peptide

#1030
20220016205
2022-01-20

METHODS OF OVERCOMING RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS

#1031
20220016204
2022-01-20

Native whey protein for improving intestinal maturation

#1032
20220016203
2022-01-20

COMPOSITIONS AND METHODS FOR PREVENTION AND REDUCTION OF METASTASIS

#1033
20220016062
2022-01-20

POWDERS CONTAINING A BUFFER SALT AND AN AMINO ACID, RECONSTITUTION OF SUCH A POWDER INTO A NUTRITIONAL PRODUCT, AND METHODS OF USING SUCH A NUTRITIONAL PRODUCT

#1034
20220010300
2022-01-13

METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND IDENTIFYING TARGETS THEREFORE

#1035
20220010009
2022-01-13

Inhibitors of neuroligin 4-neurexin 1-beta protein-protein interaction for treatment of liver disorders

#1036
20220010004
2022-01-13

PROTEIN-BASED THERAPY AND DIAGNOSIS OF TAU-MEDIATED PATHOLOGY IN ALZHEIMER'S DISEASE

#1037
20220009985
2022-01-13

Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated Diseases

#1038
20220008557
2022-01-13

FUSOSOME COMPOSITIONS FOR CNS DELIVERY

#1039
20220008506
2022-01-13

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER

#1040
20220003783
2022-01-06

MYB-RELATED TRANSCRIPTION FACTOR (MYPOP) AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR TUMOR THERAPY

#1041
20220000161
2022-01-06

Dairy product and process

#1042
20210403526
2021-12-30

TMEM100 PEPTIDES AND VARIANTS THEREOF AND THEIR USE IN TREATING OR PREVENTING DISEASES OR CONDITIONS

#1043
20210403522
2021-12-30

MODIFIED LIGAND-GATED ION CHANNELS AND METHODS OF USE

#1044
20210403504
2021-12-30

METHOD TO PRODUCE AN IMMUNOGLOBULIN PREPARATION WITH IMPROVED YIELD

#1045
20210402010
2021-12-30

Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor

#1046
20210401932
2021-12-30

Treatment of age-related macular degeneration

#1047
20210401931
2021-12-30

METHODS AND MATERIALS FOR TREATING CANCER

#1048
20210395319
2021-12-23

METHODS AND COMPOSITIONS COMPRISING TAU OLIGOMERS

#1049
20210393787
2021-12-23

COMPOSITIONS AND METHODS FOR TREATING FRONTOTEMPORAL DEMENTIA

#1050
20210393699
2021-12-23

FACTORS AND CELLS THAT PROVIDE FOR INDUCTION OF BONE, BONE MARROW, AND CARTILAGE

#1051
20210389310
2021-12-16

OXIDIZED CARDIOLIPIN AS A PRO-INFLAMMATORY FACTOR

#1052
20210388044
2021-12-16

Compositions of Phosphorylated Tau Peptides and Uses Thereof

#1053
20210386823
2021-12-16

THERAPEUTIC AGENT FOR CARTILAGE DISORDER

#1054
20210386822
2021-12-16

Anticancer pharmaceutical composition containing IF1 as active ingredient

#1055
20210386821
2021-12-16

Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders

#1056
20210380652
2021-12-09

Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use

#1057
20210380650
2021-12-09

USE OF A SMALL NATIVE PEPTIDE ACTIVATOR OF SERCA PUMP FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS CHARACTERIZED BY CYTOSOLIC CALCIUM OVERLOAD

#1058
20210379200
2021-12-09

Use of cell membrane-bound signaling factors

#1059
20210379148
2021-12-09

REGULATING MUSCLE PHYSIOLOGY AND ENERGY METABOLISM USING CRYM

#1060
20210379147
2021-12-09

METHOD AND SYSTEM FOR TREATING CANCER UTILIZING TINAGL1

#1061
20210379146
2021-12-09

METHOD TO RESTORE OR IMPROVE COGNITIVE FUNCTIONS

#1062
20210379120
2021-12-09

Therapeutic treatment of skin disease with recombinant commensal skin microorganisms

#1063
20210369823
2021-12-02

Compositions and methods for treating central nervous system injury

#1064
20210369810
2021-12-02

Self-replicating cell selective gene delivery compositions, methods, and uses thereof

#1065
20210369702
2021-12-02

METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE

#1066
20210363534
2021-11-25

Compositions and methods for treating non-age-associated hearing impairment in a human subject

#1067
20210363203
2021-11-25

Modification and compositions of human secretoglobin proteins

#1068
20210361683
2021-11-25

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE CONTRACTURES

#1069
20210355210
2021-11-18

Therapeutic and diagnostic methods relating to cancer stem cells

#1070
20210355181
2021-11-18

ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS

#1071
20210355179
2021-11-18

Methods and compositions for regenerating tissues

#1072
20210353761
2021-11-18

Lipid nanoparticle formulations for delivery of MRNA

#1073
20210353712
2021-11-18

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

#1074
20210347819
2021-11-11

Process of manufacture of annexin V

#1075
20210346466
2021-11-11

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1076
20210346465
2021-11-11

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1077
20210340243
2021-11-04

METHOD FOR MODULATING APPETITE

#1078
20210340219
2021-11-04

CHIMERIC RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS METABOLISM MOLECULES MODULATING INTRACELLULAR LACTATE CONCENTRATIONS AND THERAPEUTIC USES THEREOF

#1079
20210338790
2021-11-04

INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

#1080
20210338778
2021-11-04

METHODS FOR TREATMENT OF MICROBIAL DISORDERS

#1081
20210338775
2021-11-04

PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION

#1082
20210338774
2021-11-04

PRG-4 FOR TREATING GOUT AND ITS SYMPTOMS

#1083
20210338773
2021-11-04

METHOD FOR TREATING RETINAL DEGENERATION DISEASE BY ADMINISTERING NUCLEOLIN POLYNUCLEOTIDE OR POLYPEPTIDE

#1084
20210332093
2021-10-28

FUSED IN SARCOMA (FUS) NUCLEAR TRANSLOCATION INHIBITORS FOR PREVENTING FIBROSIS

#1085
20210330812
2021-10-28

TREATMENT OF RETINAL DEGENERATION USING GENE THERAPY

#1086
20210330743
2021-10-28

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1087
20210330742
2021-10-28

PHARMACEUTICAL COMPOSITION COMPRISING RUNX3 PROTEIN AND CDK4 INHIBITOR OR mTOR INHIBITOR COTREATMENT FOR PREVENTION OR TREATMENT OF CANCER

#1088
20210330740
2021-10-28

Runx3 modified protein for prevention or treatment of cancer

#1089
20210330600
2021-10-28

NANOPARTICLE COMPOSITIONS FOR EFFICIENT NUCLEIC ACID DELIVERY AND METHODS OF MAKING AND USING THE SAME

#1090
20210324043
2021-10-21

ApoC-II mimetic peptides

#1091
20210324023
2021-10-21

MODULATING IMMUNE RESPONSES

#1092
20210324022
2021-10-21

Cell-penetrating cereblon recombinant fusion protein and use thereof

#1093
20210322515
2021-10-21

METHODS FOR TREATING FIBROTIC CANCERS

#1094
20210322314
2021-10-21

Use Of Liposomes To Deliver A Protein And A Gene Encoding The Protein To A Live Cell

#1095
20210317475
2021-10-14

RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS

#1096
20210317186
2021-10-14

Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein

#1097
20210317174
2021-10-14

COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES

#1098
20210315969
2021-10-14

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

#1099
20210315968
2021-10-14

Prevention and treatment of viral infection and viral infection-induced organ failure

#1100
20210315961
2021-10-14

STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS

#1101
20210315821
2021-10-14

NANOLIPOSOME COMPOSITIONS AND METHODS OF USING THE SAME

#1102
20210309718
2021-10-07

Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof

#1103
20210309715
2021-10-07

Uterine cancer treatments

#1104
20210308215
2021-10-07

Methods and compositions for treating diabetes, and methods for enriching MRNA coding for secreted proteins

#1105
20210308169
2021-10-07

METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES

#1106
20210308132
2021-10-07

FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

#1107
20210300980
2021-09-30

Osteogenic biomaterial

#1108
20210300978
2021-09-30

Delivery of NRF2 as therapy for protection against reactive oxygen species

#1109
20210300968
2021-09-30

Uterine cancer treatments

#1110
20210299243
2021-09-30

IL-10 INHIBITION FOR VACCINES AND IMMUNOTHERAPY

#1111
20210299215
2021-09-30

Use of Exosome-Based Delivery of NF-KB Inhibitors

#1112
20210299214
2021-09-30

Use of PRG4 as an anti-inflammatory agent

#1113
20210299175
2021-09-30

Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods of apoptosis

#1114
20210292385
2021-09-23

Stabilized BCL9 peptides for treatment of aberrant WNT signaling

#1115
20210290743
2021-09-23

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1116
20210290686
2021-09-23

Pathways to Generate Hair Cells

#1117
20210283224
2021-09-16

TREATMENT OF INFLAMMATORY CONDITIONS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN

#1118
20210283218
2021-09-16

IMMUNOTOLERANCE WITH HEAT SHOCK PROTEINS

#1119
20210283196
2021-09-16

Method for treating an individual suffering from a chronic infectious disease and cancer

#1120
20210277115
2021-09-09

TARGETED THERAPY FOR SMALL CELL LUNG CANCER

#1121
20210275688
2021-09-09

Methods and compositions for inhibiting oxidative stress

#1122
20210275636
2021-09-09

Compositions containing exosome carrying NF-κB inhibitors and methods of using thereof

#1123
20210275634
2021-09-09

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1124
20210275633
2021-09-09

METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES USING FAT SPECIFIC PROTEIN 27 (FSP27) COMPOSITIONS

#1125
20210275632
2021-09-09

Method for treating kidney disorders

#1126
20210275631
2021-09-09

Anticancer composition comprising cervical cancer-derived autocrine motility factor as effective component

#1127
20210275630
2021-09-09

INACTIVATION OF DNA REPAIR AS AN ANTICANCER THERAPY

#1128
20210275600
2021-09-09

Methods for diagnosis and treatment of type 1 diabetes

#1129
20210269531
2021-09-02

Anti-TrkB agonist antibodies binding to D1 domain of TrkB

#1130
20210268126
2021-09-02

TREATING SPINAL CORD INJURY (SCI) AND BRAIN INJURY USING GSX1

#1131
20210268063
2021-09-02

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1132
20210260217
2021-08-26

GENERATING GABAergic NEURONS IN BRAINS

#1133
20210260215
2021-08-26

AAV CARDIAC GENE THERAPY FOR CARDIOMYOPATHY

#1134
20210260160
2021-08-26

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1135
20210260158
2021-08-26

TRANSCRIPTION FACTOR-BASED GENERATION OF PACEMAKER CELLS AND METHODS OF USING SAME

#1136
20210260157
2021-08-26

PROPHYLACTIC USES OF PARTIALLY OR FULLY REDUCED FORMS OF HMGB1 PRIOR TO INJURY

#1137
20210260110
2021-08-26

NOVEL METHODS FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS

#1138
20210260100
2021-08-26

GLUCOCEREBROSIDE TREATMENT OF DISEASE

#1139
20210253658
2021-08-19

COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS

#1140
20210253640
2021-08-19

Immunotherapy against several tumors including lung cancer

#1141
20210252143
2021-08-19

METHODS OF TREATING CANCER USING COMBINATION THERAPY

#1142
20210238237
2021-08-05

Method of managing joint pain

#1143
20210236596
2021-08-05

METHODS FOR TREATING PEMPHIGUS DISORDERS

#1144
20210236595
2021-08-05

Method of managing joint pain

#1145
20210231684
2021-07-29

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

#1146
20210230183
2021-07-29

Compositions and methods for treating cancer

#1147
20210228743
2021-07-29

Intrathecal delivery of recombinant adeno-associated virus 9

#1148
20210228683
2021-07-29

WHEY PROTEIN CONCENTRATE IN ASSOCIATION WITH ANTITUMOUR TREATMENT

#1149
20210228628
2021-07-29

Methods of immunotherapy

#1150
20210222165
2021-07-22

Chemically Ligated RNAs for CRISPR/Cas9-lgRNA Complexes as Antiviral Therapeutic Agents

#1151
20210220487
2021-07-22

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

#1152
20210220437
2021-07-22

Compositions and Methods Relating to p62 for the Treatment and Prophylaxis of Age-Related Macular Degeneration

#1153
20210220314
2021-07-22

AMINO ACID COMPOSITION FOR ENABLING FULFILMENT OF THE AMINO ACID REQUIREMENTS OF A MONOGASTRIC ANIMAL SUCH AS A HUMAN OR A PIG

#1154
20210220306
2021-07-22

Treatment and diagnosis of melanoma

#1155
20210214394
2021-07-15

ALZHEIMER'S DISEASE TREATMENT METHOD

#1156
20210213099
2021-07-15

Carrier composition for eye drops and pharmaceutical composition including the same

#1157
20210206822
2021-07-08

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

#1158
20210205409
2021-07-08

METHOD FOR THE TREATMENT OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY IN NEWBORNS

#1159
20210205403
2021-07-08

Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal Cells

#1160
20210198327
2021-07-01

SUMO AND USES THEREOF

#1161
20210196830
2021-07-01

GLYPISOME AS AN ENHANCER OF ANGIOGENIC GROWTH FACTOR ACTIVITY

#1162
20210196795
2021-07-01

THERAPEUTIC USE OF VEGF-C AND CCBE1

#1163
20210196788
2021-07-01

TEAR LIPOCALIN MUTEINS BINDING IL-4 R ALPHA

#1164
20210196787
2021-07-01

AGENT FOR ENHANCING PHAGOCYTOSIS ABILITY OF NEUTROPHILS

#1165
20210196760
2021-07-01

PHARMACEUTICAL COMPOSITION FOR TREATING CARTILAGE DAMAGE, COMPRISING NASAL SEPTUM CHONDROCYTES

#1166
20210196731
2021-07-01

COMPOSITIONS AND METHODS FOR TREATING OCULAR INFLAMMATION AND OCULAR SCARRING

#1167
20210196633
2021-07-01

CNS delivery of mRNA and uses thereof

#1168
20210189427
2021-06-24

COMPOSITIONS AND METHODS FOR GENE DELIVERY TO THE AIRWAYS AND/OR LUNGS

#1169
20210188968
2021-06-24

IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases

#1170
20210188955
2021-06-24

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING SICKLE-CELL DISEASE

#1171
20210188915
2021-06-24

HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE

#1172
20210188889
2021-06-24

Platinum compounds for binding guanine quadruplexes

#1173
20210187122
2021-06-24

MESSENGER RNA THERAPY FOR THE TREATMENT OF FRIEDREICH'S ATAXIA

#1174
20210187069
2021-06-24

DOMINANT NEGATIVE SARM1 MOLECULES AS A THERAPEUTIC STRATEGY FOR NEURODEGENERATIVE DISEASES OR DISORDERS

#1175
20210187068
2021-06-24

Lipopolysaccharide-binding protein for use in a method of treating alzheimer's disease

#1176
20210187034
2021-06-24

Processes for making and using a mesenchymal stem cell derived secretome

#1177
20210186949
2021-06-24

HEAT SHOCK PROTEINS AND CHOLESTEROL HOMEOSTASIS

#1178
20210186943
2021-06-24

OTIC FORMULATIONS FOR DRUG-INDUCED OTOTOXICITY

#1179
20210181196
2021-06-17

Autoantibodies to Septin-7 and diagnosis of neurological disease

#1180
20210180069
2021-06-17

STRUCTURE, MANUFACTURING AND USES OF HUMAN-DERIVED CELL-PERMEABLE PEPTIDES CONJUGATED WITH SPECIFIC BIOLOGICALLY ACTIVE CARGO PEPTIDES

#1181
20210180031
2021-06-17

RECOMBINANT AAVS HAVING USEFUL TRANSCYTOSIS PROPERTIES

#1182
20210179712
2021-06-17

Compositions and methods for using the CD2-based signaling pathways to block HIV infection

#1183
20210179697
2021-06-17

IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES

#1184
20210179680
2021-06-17

POLYPEPTIDE, DERIVATIVES THEREOF, AND APPLICATION THEREOF IN PREPARATION OF DRUGS HAVING RESISTANCE TO PULMONARY FIBROSIS

#1185
20210177991
2021-06-17

Frataxin expression constructs

#1186
20210177907
2021-06-17

ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT

#1187
20210177741
2021-06-17

Methods for treatment of Duchenne muscular dystrophy with follistatin polypeptides

#1188
20210171636
2021-06-10

Inhibition of cytokine-induced SH2 protein in NK cells

#1189
20210170004
2021-06-10

XBP1, CD138, AND CS1 PEPTIDES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE PEPTIDES, AND METHODS OF USING SUCH PEPTIDES AND COMPOSITIONS

#1190
20210169978
2021-06-10

Alterations in Endothelin Receptors Following Hemorrhage and Resuscitation by Centhaquin

#1191
20210169976
2021-06-10

Human milk fortifier composition

#1192
20210169973
2021-06-10

Inhibitor of IGFBP3/TMEM219 Axis and Diabetes

#1193
20210163566
2021-06-03

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

#1194
20210163557
2021-06-03

METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY

#1195
20210163551
2021-06-03

DOMINANT NEGATIVE CEBPB AND CEBPD PROTEINS AND METHODS OF USE FOR DECREASING VIABILITY OF NEOPLASTIC CELLS

#1196
20210162005
2021-06-03

Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide

#1197
20210162004
2021-06-03

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1198
20210154268
2021-05-27

COMBINATION THERAPY USING A PEPTIDE

#1199
20210154267
2021-05-27

TREATMENT OF CANCER BY ACTIVATING ENDOGENOUS CRYPTIC AMYLOIDOGENIC AGGREGATING PEPTIDES

#1200
20210154262
2021-05-27

Endoplasmic reticulum stress as a predictive tool in cancer therapy and a combination therapy for the treatment of cancer